Sonoma Pharmaceuticals (SNOA) Divestments (2015 - 2020)

Sonoma Pharmaceuticals' (SNOA) quarterly Divestments came in at $610000.0 in Q2 2020, down 86.56% quarter-over-quarter from $4.5 million in Q2 2015.

Sonoma Pharmaceuticals (SNOA) Divestments (2015 - 2020) Analysis & Trends

Sonoma Pharmaceuticals' Divestments history runs 2 years deep, the most recent figure standing at $610000.0 for Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 42.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.28 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 63.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Sonoma Pharmaceuticals 179.80 -2.40 Mn 2.18 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2020 610,000.00
Jun 30, 2015 4.54 Mn